Are the benefits of new cancer drugs worth the cost?
An international research group including scientists from Italy, the United States, Ireland, and Israel have published a three-year analysis of the Mesothelioma (Me) drug trial, Check-Mate 743 (CM-743). The trial studied ...
Dec 21, 2022
0
6